Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: ONYX PHARMACEUTICALS
Client-Reported Lobbying Expenses
$460K
59 filings
Firm Income Reported for This Client
$985K
Not substituted for client expenses
Summary
ONYX PHARMACEUTICALS is an organization, based in DC. Its political footprint includes $460K in client-reported lobbying expenses, $985K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Medical/Disease Research/Clinical Labs, Budget/Appropriations, Medicare/Medicaid. Political activity spans from 2011 to 2016.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Activity data: Senate LDA